I’m obviously very glad the charges were dropped, but, as this tweet says, it doesn’t undo the harm— the financial, emotional, and personal implications will continue to exist. There was just no reason to put Brittany Watts (or anyone) through this

Our Monthly Abortion Provision Study now includes #abortion data from January-October 2023. The latest research show that the number of abortions in 2023 is set to exceed the total number of abortions in 2020.🧵

We’re excited to welcome Jessica Valenti & experts from ACLU of Illinois URGE for a robust panel discussion on the future of our post-#Roe democracy. 📣 Join in to hear about the importance of data in shaping protective #SRHR policies. Learn more & register: gu.tt/420rVEw

We've long admired Cecile’s tireless work for bodily autonomy and reproductive rights for all. Her unwavering commitment is truly inspiring, persisting even in the face of grave illness. Cecile Richards you are a beacon of strength, sending you heartfelt support & gratitude🌟

NEW op-ed: Our research & policy experts discuss how a recently retracted study has been used as part of a baseless court case to restrict access to the medication abortion drug mifepristone in the US—and why that retraction was justified. More The Hill: thehill.com/opinion/health…

I spoke to the The New Republic about the IVF ruling— all these issues— abortion, contraception, everything— are linked. And also as a very dedicated auntie to kids who wouldn’t be here without IVF— angry is an understatement newrepublic.com/post/179222/iv…

On March 26, the US Supreme Court will hear a critical case on #MedicationAbortion—the culmination of a years-long anti-abortion strategy. What role does flawed science play in this attack? Our experts Rachel K. Jones & Kelly Baden weigh in. guttmacher.org/article/2024/0…

Last week, #familyplanning experts from the around the 🌍convened in Mombasa 🇰🇪 for the IUSSP Expert Group meeting on "Assessing approaches to demand-side family planning measurement with a reproductive justice and rights framework".

Today, #SCOTUS will hear a critical case on #mifepristone—the culmination of a years-long anti-abortion strategy. The Court must respect the scientific evidence that mife is safe, effective & essential. Full statement from our Acting Co-CEO Destiny Lopez: guttmacher.org/2024/03/guttma…

Today in Washington DC, our Acting Co-CEO Destiny Lopez & staff join advocates from across the US to remind #SCOTUS that there's only one reasonable decision: honor the FDA’s evidence-based approval of mifepristone & preserve access without any new restrictions. #BansOffOurBodies

absolutely devastating news out of FL for abortion access. while the approval of the ballot initiative was approved, the devastation of a 6 week ban that will be in effect in just 30 days will be felt through the entire region

Our new op-ed in TheHillOpinion exposes the anti-abortion movement for what it truly is, and spoiler, there's nothing "pro-life" about it. Our Acting Co-CEO Destiny Lopez and VP for Public Policy Kelly Baden break it down: thehill.com/opinion/judici…

I don't know how to raise my daughter in a country where the Supreme Court is debating how many organs are ok for women to lose before providing healthcare

Join us for a #CPD57 side event with UN DESA & HRP on 30 years of #SRHR progress & challenges. Hear from experts Jonathan Marc Bearak, Onikepe Owolabi, Nelly Munyasia Reproductive Health Network Kenya, Vladimira Kantorova UN DESA & Jenny Cresswell World Health Organization (WHO). Attend in person or online: desa.webex.com/desa/j.php?MTI…

New report out today, summing up the causal effects of #GlobalGagRule’s most recent implementation in Ethiopia and Uganda -- thanks to a multiyear collaboration with partners, colleagues including Assefa Seme Simon Kibira Fred Makumbi and Solomon Shiferaw Dr. Scientist

Our experts are closely tracking the many impacts of the Dobbs decision. Learn more about the extent of these harms in our new policy analysis by Kelly Baden Joerg Dreweke & Candace Gibson: guttmacher.org/2024/05/clear-…

Our acting co-CEO Destiny Lopez testified before the US Senate on June 4, 2024, on the state of abortion access since the Dobbs decision. As she made clear, we need urgent policy action to guarantee the full spectrum of reproductive care for all. More: gu.tt/4e2LmSN

Our data scientist Isaac Maddow-Zimet testified before the US Senate on the sharp increase in out-of-state travel for abortion care.️ As our research shows, 1 in 5 abortion patients crossed state lines for care in 2023. This can't be the new norm. More: gu.tt/3VB7MDr

👇👇👇👇

There is no such thing as a “post-birth abortion.” That’s it. That’s the tweet.